On December 20, 2024, Lexicon Pharmaceuticals announced that it received a complete response letter from the FDA regarding the drug sotagliflozin (Zynquista). The latest communication from the FDA aligns with a previously issued letter noting deficiencies regarding Lexicon’s new drug application for Zynquista as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease. ...
Nephrology Times
Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.
Advertisement
Latest News
A study assessed acute kidney injury risk with PPI use in patients with cancer who received immune checkpoint inhibitors.
Listen to the discussion of Chapter 16 of Dr. Burton Rose's book, focused on edematous states.
Freely Filtered looks at the landmark study of finerenone in heart failure with preserved ejection fraction (FINEARTS study).
A trial studied the efficacy of extracorporeal blood purification in reducing cardiac surgery-associated acute kidney injury.
A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies.
A study examined the impact of hemodiafiltration versus hemodialysis in patients with end-stage renal disease.
CERTAIN registry data were used to assess age-related differences in outcomes among pediatric kidney transplant recipients.
Researchers studied the clinical relevance of allograft microvascular inflammation in kidney transplantation.
A study examined the association of APOL1 risk variants and genotypes with chronic kidney disease among West Africans.
The American College of Rheumatology issued a summary of a new guideline for lupus nephritis.
Advertisement
Expert Interviews
In Print
ASN Kidney Week 2024, the future of nephrology, the relationship between CKD and osteoarthritis, and more.
Tribute to Nicoloas Madias, amino acid infusion to reduce AKI risk, felzartamab results, and more.
Conferences
The American Society of Nephrology's annual meeting to highlight the latest scientific and medical advances in the field
ATC provides a forum for exchange of new scientific and clinical information relevant to transplantation.
The annual nephrology meeting organized by the European Renal Association
The National Kidney Foundation's premier educational event designed for the interprofessional kidney health team
Podcasts
Listen to the discussion of Chapter 16 of Dr. Burton Rose's book, focused on edematous states.
Freely Filtered looks at the landmark study of finerenone in heart failure with preserved ejection fraction (FINEARTS study).
The Filtrate rerecorded their episode on the PRAECIS trial regarding a blood test for preeclampsia due to listener feedback.
We had a great NephJC get together. We recorded the whole event and packaged it into a podcast.
Expert Columns
It is important to understand the challenges Medicare Advantage plans present for ESRD care.
Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
Critical Financial Shifts Ahead: How CY 2025 ESRD PPS Changes Could Impact Small Dialysis Facilities
Sarah Tolson reviews the key financial implications of the CMS proposed rule for the ESRD Prospective Payment System.
Ajay Singh pays tribute to the late nephrologist and researcher Nicolaos Madias, MD, of Tufts Medical Center.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
It is essential for nephrology practices and dialysis centers to have backup methods for processing claims.
Knowledge Hubs
Advertisement
Advertisement
Nephrology Times Chair
Ajay K. Singh, MBBS, FRCP, MBASenior Nephrologist, Brigham and Women’s Hospital | Senior Associate Dean, Harvard Medical School
Editorial Board
Mohamed G. Atta, MD, MPHProfessor of Medicine, Johns Hopkins School of Medicine
Timothy E. Bunchman, MDProfessor and Director, Pediatric Nephrology, Transplantation, and Rheumatology, Children’s Hospital of Richmond at VCU
Suphamai Bunnapradist, MD, MSProfessor of Medicine, David Geffen School of Medicine at UCLA | Research Director, Kidney Transplant Program, UCLA
Fernando C. Fervenza, MD, PhDProfessor of Medicine, Division of Nephrology and Hypertension, Mayo Clinic
Kenneth A. Liss, DOPartner, Hypertension and Nephrology Association, Eatontown, NJ
Joel M. Topf, MD, FACPAssistant Clinical Professor of Medicine, Oakland University William Beaumont School of Medicine
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.